NovaBridge Biosciences
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2018 | — | — | $241.5M |
| FY2019 | $96.0M | $249.6M | $163.4M |
| FY2020 | $108.3M | $970.7M | $729.3M |
| FY2021 | $163.5M | $878.9M | $552.9M |
| FY2022 | $168.7M | $590.6M | $342.9M |
| FY2023 | $126.3M | $368.9M | $291.5M |
| FY2024 | $11.5M | $212.7M | $68.3M |
| FY2025 | $29.6M | $260.5M | $210.6M |